Main Street Capital Corporation vs Revvity Inc — how do they compare? Main Street Capital Corporation trades at $54.6 (market cap $5.08B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: Revvity Inc is far larger — about 2.3× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays the higher dividend (8.02%). Which is the better fit depends on your goals.
| MAIN | RVTY | |
|---|---|---|
Market Cap | $5.08B | $11.87B |
Sector | Financials | Technology |
52-Week High | $67.54 | $117.75 |
52-Week Low | $49.63 | $82.26 |
Dividend Yield | 8.02% | 0.26% |
Enterprise Value | — | $14.36B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.
The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.
Trailing returns across standard periods
Latest headlines on both assets
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →